Dr. Irina Borodina,CSO & Co-Founder
Irina is the founder of BioPhero. She has extensive experience in the development of yeast-based fermentation platforms. She also heads a research group in metabolic engineering of yeast cell factories at the Novo Nordisk Foundation Center for Biosustainability. Irina holds a Ph.D. in biotechnology from the Technical University of Denmark.
Mr. Kristian Ebbensgaard, CEO
Kristian has extensive experience in business management and development of global biotechnology markets in several industries, including food, beverage alcohol as well as pulp and paper. He has lived and worked in Denmark, France, Switzerland and India. He holds an M.Sc. Econ. from the Copenhagen Business School.
Mr. Mikael Bechsgaard, CFO/CMO
Mikael is combining his experience from IT start-up and management consultancy with 15 years of senior commercial positions in industrial biotech. He holds a M.Sc. Econ. from the Copenhagen Business School, an executive leadership education from INSEAD and part-time chemistry studies.
Dr. Jesper Dohrup, CTO
Jesper is an experienced commercial manager and industrial process engineer with extensive experience in industrial biomass processing and biorefineries from start-up to commercial take-off. He holds a Ph.D. in chemistry from the Technical University of Denmark.
Board of Directors
Mr. Hadyn Parry, Chairman
Hadyn Parry is an experienced executive from the biotechnology, life science, and agro-chemical industries. As the CEO of Oxitec, he established the world's first company to use genetically engineered male insects to combat mosquito-borne diseases and major pests of agricultural crops. Hadyn holds a BA in international history and politics followed by an executive leadership education from INSEAD.
Dr. John Hamer, Board Member, DCVC Bio
John is a managing partner at DCVC Bio, a venture capital fund with a focus on life science companies. He has prior experience from Monsanto (today’s Bayer) and the venture capital and private equity firm Burrill & Company. His entrepreneurial career started at Paradigm Genetics (NASDAQ: PDGM), where he became president and CEO following the company’s IPO. John holds a MSc in biological sciences from the University of Windsor and a PhD in microbiology from the University of California.
Dr. Michael Lee, Board Member, Syngenta Group Ventures
Michael is a managing director at Syngenta Group Ventures following several years at Unilever’s corporate venturing group based in the US and UK investing in early-stage companies. Michael holds a BSc in Zoology and a PhD in insect biochemistry from the University of Durham and is a Fellow of the Royal Entomological Society.
Dr. Thomas Grotkjær, Board Member, Novo Seeds
Thomas is an investor and principal at Novo Seeds with a focus on investments in industrial biotechnology. His extensive experience in biotechnology business development stems from companies such as Novozymes, Fluxome, Carlsberg and BASF. Thomas holds an MSc in chemical engineering and a PhD in metabolic engineering and bioinformatics from the Technical University of Denmark.
Lactobio Chief Operating Officer and co-founder with long-term experience as R&D manager and scientist in probiotics and antimicrobial compounds.
Novozymes Vice President of operations in Europe, Middle East and Africa with expertise in large-scale industrial fermentation and processes.